HGH Holdings Ltd. (SGX:5GZ)
Singapore
· Delayed Price · Currency is SGD 0.0190
0.00 (0.00%)
At close: Mar 6, 2026
HGH Holdings Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 54.64 | 21.32 | 20.03 | 21.59 | 20.07 | Upgrade
|
| Revenue Growth (YoY) | 156.32% | 6.41% | -7.20% | 7.56% | 71.60% | Upgrade
|
| Cost of Revenue | 40.69 | 15.24 | 16.25 | 17.75 | 15.52 | Upgrade
|
| Gross Profit | 13.96 | 6.08 | 3.78 | 3.84 | 4.55 | Upgrade
|
| Selling, General & Admin | 7.52 | 5.99 | 5.49 | 6.25 | 5.99 | Upgrade
|
| Other Operating Expenses | 0.01 | 0.03 | 0.01 | 0.11 | 0.94 | Upgrade
|
| Operating Expenses | 7.94 | 6.33 | 5.43 | 6.21 | 7.26 | Upgrade
|
| Operating Income | 6.02 | -0.25 | -1.65 | -2.38 | -2.71 | Upgrade
|
| Interest Expense | -0.38 | -0.28 | -0.16 | -0.17 | -0.17 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.08 | 0.13 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.04 | -0.04 | -0.05 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.43 | 0.2 | 1.08 | 0.59 | 0.36 | Upgrade
|
| EBT Excluding Unusual Items | 6.09 | -0.21 | -0.64 | -2 | -2.52 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.03 | 0.22 | 0.14 | Upgrade
|
| Asset Writedown | - | -0.13 | - | - | -1.01 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.37 | Upgrade
|
| Pretax Income | 6.09 | -0.33 | -0.61 | -1.78 | -3.02 | Upgrade
|
| Income Tax Expense | 0.89 | -0.1 | -0.28 | -0.27 | -0.73 | Upgrade
|
| Earnings From Continuing Operations | 5.2 | -0.23 | -0.32 | -1.51 | -2.29 | Upgrade
|
| Net Income to Company | 5.2 | -0.23 | -0.32 | -1.51 | -2.29 | Upgrade
|
| Minority Interest in Earnings | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 | Upgrade
|
| Net Income | 5.22 | -0.2 | -0.31 | -1.5 | -2.27 | Upgrade
|
| Net Income to Common | 5.22 | -0.2 | -0.31 | -1.5 | -2.27 | Upgrade
|
| Shares Outstanding (Basic) | 1,801 | 1,781 | 1,781 | 1,781 | 1,781 | Upgrade
|
| Shares Outstanding (Diluted) | 1,801 | 1,781 | 1,781 | 1,781 | 1,781 | Upgrade
|
| Shares Change (YoY) | 1.15% | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | -3.06 | -2.57 | 2.71 | -0.3 | 1.75 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | 0.00 | - | 0.00 | Upgrade
|
| Gross Margin | 25.54% | 28.51% | 18.87% | 17.77% | 22.69% | Upgrade
|
| Operating Margin | 11.01% | -1.16% | -8.23% | -11.00% | -13.50% | Upgrade
|
| Profit Margin | 9.56% | -0.94% | -1.53% | -6.97% | -11.32% | Upgrade
|
| Free Cash Flow Margin | -5.60% | -12.06% | 13.53% | -1.41% | 8.70% | Upgrade
|
| EBITDA | 10.75 | 3.4 | 1.93 | 1.32 | 1.76 | Upgrade
|
| EBITDA Margin | 19.68% | 15.96% | 9.61% | 6.10% | 8.78% | Upgrade
|
| D&A For EBITDA | 4.73 | 3.65 | 3.57 | 3.69 | 4.47 | Upgrade
|
| EBIT | 6.02 | -0.25 | -1.65 | -2.38 | -2.71 | Upgrade
|
| EBIT Margin | 11.01% | -1.16% | -8.23% | -11.00% | -13.50% | Upgrade
|
| Effective Tax Rate | 14.60% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.